IEX·IDEX Corporation
IEX|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $2.23 | - | - |
| Q2'26 | $2.13 | $2.32 | +8.9% |
| Q1'26 | $2.09 | $2.00 | -4.2% |
| Q4'25 | $2.06 | $2.10 | +1.8% |
| Q3'25 | $1.93 | $2.03 | +5.2% |
| Q2'25 | $1.99 | $2.07 | +4.0% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $936M | - | - |
| Q2'26 | $915M | $921M | +0.7% |
| Q1'26 | $889M | $887M | -0.2% |
| Q4'25 | $891M | $899M | +0.9% |
| Q3'25 | - | $879M | - |
| Q2'25 | - | $865M | - |
Market Data
IEX Stock Snapshot
IEX is currently trading at $234.39, giving IDEX Corporation a market cap of 17.58B and a P/E ratio of 33.8. Today's range spans $231.37–$235.98, with shares opening at $234.41 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 73/100 (BUY).
Over the past year IEX has traded between $158.19 and $243.80 - the current price is +48.2% off the 52-week low and -3.9% from the high.
What IEX has right now - BUY signal, 73/100 technical score, neutral sentiment at -/100, price $234.39 (near 52-week highs) - is the profile that shows up in screens looking for Industrials growth stories with technical confirmation. (P/E: 33.8) At 17.58B in capitalization, the risk/reward of a setup like this is often better than in mega-cap peers where the same signal translates to a smaller percentage move. Range: $158.19–$243.80.
The combination of a BUY signal (73/100) and neutral news sentiment (-/100) puts IEX on the screens of active managers who run quality-momentum overlays, a cohort that can build meaningful positions at 17.58B in Industrials market cap without immediately moving the stock. At $234.39 (near 52-week highs in the $158.19–$243.80 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.
Company Insights: IDEX Corporation (IEX)
IDEX’s cost structure remains a key driver of its operating leverage, with a share repurchase program that has reclaimed 25.04% of the float since 2008, amounting to $1.74 billion in buybacks. The program has accelerated in the last quarter, tightening the earnings base and boosting EPS per share. In Q2 2026, EPS rose to $2.32 from $2.00 in Q1, beating the $2.13 consensus estimate and illustrating improved operating efficiency. Revenue growth of 6.5% YoY in Q2, coupled with disciplined cost control, has lifted margins and reinforced the company's leverage profile. The company’s cost structure remains resilient, with fixed manufacturing overheads absorbed by an expanding product mix, allowing for margin expansion without proportional revenue spikes.
Margin trajectory has been positive, as evidenced by the jump in EPS and the 45% year‑to‑date return that the stock has delivered, outperforming many industrial peers. The company’s operating margin has improved from 12.5% in Q1 to 13.8% in Q2, reflecting tighter variable costs and higher utilization of capital equipment. Share count contraction has amplified earnings per share, driving the forward PE to 33.35, slightly above the peer average of 29.2. Management’s focus on automation and precision components has further reduced cost per unit, creating a virtuous cycle of margin expansion. The 6.7% one‑month gain and 9.1% three‑month gain underscore the momentum in the stock’s price action.
Valuation metrics place IDEX at a modest premium to its peers, with a forward PE of 33.35 versus 29.2 for the peer group. The current price of $234.46 sits 27.5% above the 52‑week low and 17.7% below the high, offering a potential upside if the share count continues to shrink. Analysts have recently lifted the consensus target to $240, implying only a 2.6% upside from today. The rising sentiment score of 64, up 8 points over the past 14 days, suggests growing investor confidence. However, the narrow upside window indicates that the market is pricing in most of the expected margin expansion already.
The Fluid & Metering Technologies segment remains the revenue anchor, while Health & Science Technologies delivers higher margins and growth potential. Fire & Safety/Diversified Products has broadened the company’s market reach into automotive and aerospace, diversifying revenue streams. Recent product launches in the HST segment, including advanced analytical instruments, are expected to drive incremental revenue in the high‑margin portion of the business. Cross‑segment technology transfer, such as sensor integration from HST into FMT products, reduces R&D spend and accelerates time‑to‑market for new offerings. The company’s diversified product mix mitigates concentration risk and supports stable earnings even during cyclical slowdowns.
Macroeconomic headwinds, such as tightening commodity prices and slowed industrial investment, could dampen demand for IDEX’s fluid‑handling and safety equipment. Competitive pressure from larger industrial conglomerates may erode market share if the company cannot sustain its pricing advantage. Currency fluctuations and supply‑chain disruptions pose additional risks to the company’s global operations and cost structure. Despite these risks, the company’s disciplined cost base and robust share repurchase program provide a cushion against short‑term volatility. Investors should monitor upcoming earnings releases to confirm the upward trajectory and assess the impact of macro factors on demand.
Share Repurchase
IDEX has reclaimed roughly 25.04% of its shares since 2008, a cumulative outlay of about $1.74 billion, tightening the earnings base and boosting EPS per share.
The buyback program, initiated in 2008, has accelerated in recent quarters, with $1.74 billion spent on repurchases, underscoring management's confidence in sustainable cash flow.
Share count contraction enhances return on equity and elevates the company's price‑to‑earnings multiple, making the stock more attractive to income‑focused investors.
Margin Discipline
Quarterly EPS rose from $2.00 in Q1 2026 to $2.32 in Q2 2026, surpassing the $2.13 consensus estimate and signaling improved operating efficiency.
Revenue growth of 6.5% YoY in Q2 2026, coupled with disciplined cost control, has lifted operating margins and reinforced the company's leverage profile.
The company’s cost structure remains resilient, with fixed manufacturing overheads absorbed by an expanding product mix, allowing for margin expansion without proportional revenue spikes.
Product Pipeline
IDEX’s pipeline includes next‑generation fluid‑handling systems and advanced analytical instruments, expected to drive incremental revenue in the high‑margin HST segment.
Recent product launches in the Fire & Safety/Diversified Products segment have broadened the company’s market reach into automotive and aerospace, diversifying revenue streams.
Management’s emphasis on automation and precision components positions the firm to capture higher‑value contracts amid industrial digitization trends.
Segment Synergy
The Fluid & Metering Technologies segment anchors the company’s revenue base, while Health & Science Technologies offers higher margin upside, creating a balanced growth engine.
Cross‑segment technology transfer, such as sensor integration from HST into FMT products, reduces R&D spend and accelerates time‑to‑market for new offerings.
Synergies also manifest in shared logistics and procurement, lowering unit costs and enhancing competitive pricing across all three segments.
Market Position
IDEX operates in over 30 countries, providing fluid‑handling, analytical, and safety solutions that serve critical infrastructure sectors like water treatment and energy.
The company’s global footprint gives it a competitive edge over peers that focus on narrower geographic markets, mitigating regional demand shocks.
Its diversified product mix reduces concentration risk, allowing the firm to maintain stable earnings even when one segment experiences cyclical slowdowns.
Valuation
With a forward PE of 33.35, IDEX trades at a modest premium to the peer average of 29.2, reflecting the market’s confidence in its margin expansion.
The current price of $234.46 sits 27.5% above the 52‑week low and 17.7% below the high, offering a potential upside if the share count continues to shrink.
Analyst consensus price target of $240 implies a modest upside of 2.6% from the current level, indicating a narrow margin for further upside under present fundamentals.
Risk Management
Macroeconomic headwinds, such as tightening commodity prices and slowed industrial investment, could dampen demand for IDEX’s fluid‑handling and safety equipment.
Competitive pressure from larger industrial conglomerates may erode market share if the company cannot sustain its pricing advantage.
Currency fluctuations and supply‑chain disruptions pose additional risks to the company’s global operations and cost structure.
Positioning IEX
IDEX’s current price of $234.46 sits 27.5% above the 52‑week low and only 17.7% below the high, positioning it near the upper end of its recent trading band. The analyst consensus target of $240 implies a modest upside of roughly 2.6% from today, suggesting a cautious stance if the share price remains near the high. Add exposure when the price approaches the 52‑week low, as the 45% year‑to‑date return indicates strong momentum and the share repurchase program continues to shrink the float. Reduce holdings if the stock trades above the target or if sentiment turns negative, as rising macro headwinds could pressure demand. Maintain a moderate allocation in a diversified portfolio, aligning with the company’s stable earnings and disciplined cost base.
Key Metrics for IEX
IDEX’s valuation hinges on how well it trims costs while expanding its automation and fluid‑handling businesses. Investors watch the company’s operating leverage, the pace of automation revenue, and the impact of its aggressive share‑repurchase program to gauge whether the current premium is justified. Quarterly EPS performance and price momentum further confirm whether the market rewards execution or penalizes volatility. These metrics together paint a picture of whether IEX can sustain growth without eroding margins.
Operating Margin Trajectory: Operating margin has become a barometer for IEX’s cost discipline as it scales its specialty machinery portfolio. In Q2 2026, the company’s EPS beat of $2.32 versus $2.13 suggested tighter manufacturing and logistics costs, nudging the margin upward. A steady rise in margin signals that IEX can convert revenue growth into higher profitability, reinforcing its premium valuation. Historically, margin gains have pushed the stock higher, while any widening of the cost base has triggered sell‑offs. Analysts will scrutinize the next quarter’s cost‑control initiatives and any changes in raw‑material pricing to assess future margin prospects. Watch for guidance on operating expenses and any announced efficiency projects that could accelerate the margin trajectory.
Automation Revenue Growth: Automation revenue growth is the engine behind IEX’s expansion into high‑margin industrial solutions. The Q2 2026 revenue of $920.6 million, slightly above the $915 million estimate, reflects a healthy uptick in demand for automated fluid‑handling systems. A growth rate above 10% per quarter would validate the company’s automation strategy and support a higher multiple. When automation sales accelerate, the stock typically rallies, whereas a slowdown can dampen investor enthusiasm. The upcoming earnings call will reveal whether the automation pipeline continues to expand or if macro‑headwinds are curbing orders. Pay close attention to any new product launches or strategic partnerships that could boost automation revenue.
Share Repurchase Impact on EPS: IEX’s share‑repurchase program has been a key driver of EPS growth, as the company has bought back roughly 25% of its shares since 2008. The Q2 2026 EPS rise to $2.32, coupled with a shrinking share count, illustrates how buybacks amplify earnings per share. A sustained increase in buyback intensity typically signals management confidence and can lift the share price. Conversely, a slowdown in repurchases often leads to a flattening of EPS and a muted market response. The next quarter’s repurchase announcements will indicate whether IEX plans to continue this earnings‑boosting strategy. Investors should monitor the buyback pace relative to cash flow and capital allocation plans.
Quarterly EPS Execution Rhythm: IEX’s EPS track record over the past seven quarters shows a mix of beats and misses: a miss in Q1 2026 ($2.00 vs. $2.09), followed by a beat in Q2 2026 ($2.32 vs. $2.13), and consistent beats in 2025. This pattern highlights the company’s ability to navigate cost pressures while delivering earnings growth. A consistent beat streak would reinforce investor confidence, whereas a series of misses could erode the premium. Historically, each EPS beat has spurred a short‑term rally, while misses have triggered a pullback. Analysts will look for a clear trend in earnings execution as a proxy for operational stability. Upcoming quarterly results will be critical to confirm whether the company can maintain its EPS momentum.
Momentum vs Peers: IEX’s price performance, 6.7% in the last month, 9.1% over three months, and 45.0% over a year, places it ahead of many industrial peers. This upward trajectory suggests that the market rewards the company’s execution and growth narrative. A continued outperformance would support the current premium, while a slowdown relative to peers could signal a re‑evaluation of the valuation. Historically, the stock has rallied when its momentum remains strong, and it has retraced when peers gain traction. The next quarter’s earnings release will be a key catalyst for momentum, especially if it confirms or exceeds expectations. Keep an eye on the 6‑month and 12‑month returns to gauge the sustainability of the current trend.
Risk Factors
IDEX’s risk landscape is dominated by company‑specific cost and margin dynamics rather than broad macro or regulatory factors. The firm’s operating leverage means that modest increases in raw material or labor costs can quickly erode profitability. Supply‑chain constraints and shifts in industrial automation demand also pose near‑term threats to revenue growth. Together, these risks could compress the multiple by 10‑15% if they materialize simultaneously.
- Margin Compression
Operating leverage amplifies the effect of cost increases on margins. If raw material costs rise or labor rates climb, the company’s gross margin could shrink by 1–2 percentage points within a single quarter. A sustained margin squeeze would erode operating income and reduce the buffer for discretionary spending. Key indicators to watch include the supplier price index, manufacturing cost reports, and the company’s own cost‑control disclosures. The compression would likely become visible within 6–12 months of a cost shock, as inventory and production adjustments take effect.
- Raw Material Cost Surge
Commodity price spikes can erode profitability. Global supply constraints or geopolitical tensions that push steel, aluminum, or energy prices higher would lift the cost of goods sold. A 5–10% rise in raw material costs could cut gross margin by roughly 0.5–1 percentage point, tightening the operating leverage. Leading signals are the WTI crude index, steel price index, and the company’s quarterly cost‑of‑goods reports. The margin impact would appear within 1–2 quarters after the price surge, as the company adjusts pricing or sourcing.
- Supply Chain Disruption
Disruptions in the global supply chain can delay production. Port congestion, shipping delays, or shortages of key components could push back delivery schedules. Production slowdowns would raise inventory carrying costs and could force the company to offer discounts, compressing revenue. Indicators such as the shipping index, component lead times, and supplier capacity reports would flag emerging bottlenecks. The adverse effects could materialize abruptly, especially during peak demand periods, and may persist until the supply chain stabilizes.
- Automation Demand Slowdown
A slowdown in industrial automation adoption could dampen growth. Economic slowdowns or capital‑expenditure cuts by customers would reduce demand for the company’s fluid‑handling and precision‑component products. Lower sales in the FMT and HST segments would erode revenue growth and put pressure on margins. Market data on industrial automation spending and capital‑expenditure trends would serve as early warning signs. The decline would likely unfold over 12–18 months as customers defer or cancel projects.
- EPS Miss Momentum
The Q1 2026 earnings miss of $0.09 per share signals potential volatility. The miss, driven by a $0.09 shortfall in EPS, suggests that cost overruns or weaker‑than‑expected sales may have impacted profitability. If the company continues to miss guidance, the market could reassess its valuation, potentially tightening the price‑to‑earnings multiple. Analysts will monitor subsequent earnings releases and any revisions to guidance for clues. The impact would be felt immediately after the earnings announcement and could linger if the miss is perceived as a trend.
What Moves IEX Stock?
IDEX Corporation's stock performance is primarily driven by its consistent earnings beats and the strategic growth initiatives within its diverse business segments. The company's ability to navigate demand across its Fluid & Metering Technologies and Health & Science Technologies segments is a key indicator. Recent news sentiment has been rising, currently sitting at 70/100, reflecting increased investor interest.
Earnings Performance
IDEX Corporation's financial health is closely tied to its ability to meet and exceed analyst expectations for earnings per share (EPS) and revenue. The company operates in specialized industrial machinery markets, where consistent operational execution and efficient cost management are critical for profitability. Strong earnings performance signals effective management and robust underlying demand for its products and solutions.
The company has a history of positive earnings surprises, having beaten EPS estimates for the last four reported quarters, including Q4 2025 with actual EPS of $2.10 against an estimate of $2.06. Revenue in Q4 2025 also surpassed expectations, reaching $899 million versus an estimate of $891 million. This consistent performance demonstrates a reliable operational track record.
When IDEX reports earnings that beat estimates, its stock price typically reacts positively, often leading to an upward re-rating of its valuation multiples. Conversely, a miss on earnings could trigger a sharp sell-off as investors reassess the company's growth prospects. Investors should monitor forward guidance and management commentary on operational efficiency during earnings calls.
Segmental Growth
IDEX's diversified structure, with segments like Fluid & Metering Technologies (FMT) and Health & Science Technologies (HST), means that growth is not reliant on a single market. FMT serves critical sectors such as water treatment and energy, while HST caters to life sciences and analytical instruments. The performance of these distinct segments, influenced by their respective end-market dynamics and acquisition strategies, directly impacts overall company growth.
Recent analyst reports highlight strong performance in FMT and HST, driven by demand in water, pharmaceutical, and semiconductor markets. Strategic acquisitions, such as the recent Mott acquisition, are also contributing to growth, though concerns about organic revenue stagnation over the past two years persist. The company's ability to integrate acquisitions and foster organic expansion is key.
Positive developments or strong guidance from either the FMT or HST segments can lead to stock price appreciation, especially if they signal accelerating organic growth. Conversely, weakness in these key areas or a failure to demonstrate effective integration of acquired businesses could pressure the stock. Investors should watch for updates on specific segment performance and acquisition synergies.
Analyst Sentiment
Analyst ratings and price targets serve as important indicators of Wall Street's perception of IDEX Corporation's future prospects. A consensus of positive ratings and upward revisions to price targets can influence investor confidence and drive stock demand. The composition of analyst recommendations, particularly the absence of sell ratings, suggests a generally favorable outlook.
The stock has seen recent analyst activity, including BMO Capital initiating coverage with a "Market Perform" rating and a $214 price target. The mean analyst target currently stands at $223.54, with a high of $250.0, indicating a significant upside potential from the current price. The overwhelming majority of analysts (11 out of 19) recommend a buy.
An upgrade in analyst ratings or a significant increase in the consensus price target often provides a catalyst for the stock price to move higher, as it signals increased conviction from institutional research. Conversely, a downgrade or a reduction in price targets could lead to selling pressure. Monitoring the trend of analyst sentiment and specific commentary accompanying rating changes is crucial for anticipating stock movements.
Key insight: IDEX Corporation's stock is best understood through its consistent earnings execution and its strategic approach to growth via diversified segment performance and acquisitions. While analyst sentiment is currently supportive, the key takeaway for investors is the company's ability to translate its operational strengths into sustainable organic growth amidst market cyclicality.
Frequently Asked Questions About IEX
Is IDEX (IEX) stock a good investment in 2026?
The bull case for IDEX centers on its diversified portfolio across Fluid & Metering Technologies, Health & Science Technologies, and Fire & Safety/Diversified Products, each contributing to a steady revenue base. In Q2 2026 the company posted EPS of $2.32, beating the $2.13 estimate, and revenue of $920.6 million versus a $915 million forecast, signaling operational resilience. With a forward P/E of 33.35 and a market cap of $17.3 billion, the stock trades near the upper end of its 52‑week range, yet still offers upside if margin expansion materializes. Risks include macro‑economic headwinds that could dampen industrial demand and the potential for supply‑chain disruptions. Overall, the firm’s share‑buyback program and automation‑related growth provide a solid foundation for investors seeking margin‑driven returns.
What drives IDEX (IEX) stock price?
Primary price drivers for IDEX are its recurring revenue streams from fluid‑handling systems and precision components, coupled with a robust share‑repurchase program that has reduced share count by 25.04% since 2008. The company’s ability to execute cost efficiencies across its three segments has helped maintain gross margins above 30%, a key lever for earnings growth. Additionally, the recent upgrade to a $240 target by DA Davidson reflects confidence in IDEX’s product pipeline and expanding market share. Market sentiment, currently rising with a 64 score, also contributes to upward price momentum. Finally, the 45% year‑to‑date return underscores the market’s positive outlook.
How has IDEX (IEX) stock performed this year?
Over the past 12 months IDEX’s shares have climbed 45%, outperforming the sector average of roughly 30% and nearing the upper 52‑week high of $243.80. The 6‑month return stands at 18.5%, while the 3‑month gain is 9.1%, indicating a steady acceleration in investor confidence. Compared to its peers, whose average P/E sits at 29.2, IDEX trades at 33.35, suggesting a premium tied to its operational leverage. The upward trend aligns with the company’s recent earnings beat in Q2 2026. Market participants appear to reward IDEX’s margin discipline and share‑buyback activity.
What are the risks of buying IDEX (IEX)?
Key risks include potential slowdown in industrial spending due to global economic uncertainty, which could compress revenue growth. Supply‑chain constraints in the specialty machinery sector may elevate input costs, eroding operating margins. Regulatory changes targeting environmental standards for fluid‑handling equipment could increase compliance expenses. Additionally, the company’s reliance on a few large customers in certain segments exposes it to concentration risk. Finally, the premium valuation relative to peers may leave little room for price correction if earnings miss expectations.
What is IDEX's competitive positioning in the specialty industrial machinery sector?
IDEX maintains a competitive edge through a diversified product mix that spans fluid‑handling, health & science, and fire‑safety equipment, reducing exposure to any single market cycle. Its strong brand recognition in water treatment and energy sectors, combined with a global footprint, allows it to capture cross‑border opportunities. The company’s investment in automation and digital solutions enhances operational efficiency and differentiates its offerings from traditional competitors. While peers such as AMETEK and Allegion also operate in industrial machinery, IDEX’s higher gross margin and share‑buyback program provide a financial advantage. Market sentiment remains positive, reflected in a rising sentiment score of 64.
How has IDEX (IEX) revenue trended over recent quarters?
Revenue has displayed a modest dip in Q1 2026 at $886.9 million compared to $899.1 million in Q4 2025, but rebounded sharply in Q2 2026 to $920.6 million, surpassing the $915 million estimate. The YoY revenue trajectory shows a slight decline from Q4 2025 to Q1 2026, followed by a strong recovery in Q2 2026. This pattern illustrates the company’s ability to rebound after a temporary slowdown, likely driven by seasonal demand in the industrial sector. The consistent upward trend in revenue supports the narrative of operational resilience. Analysts have noted this rebound as a positive indicator for future earnings.
What did IDEX (IEX) report in Q2 2026 earnings?
In Q2 2026 IDEX reported diluted EPS of $2.32, beating the $2.13 consensus estimate, while revenue rose to $920.6 million, exceeding the $915 million forecast. The earnings beat was driven by stronger sales in the Fluid & Metering Technologies segment, which grew by 6% YoY. Gross margin remained steady at 31%, indicating effective cost control. The company also highlighted ongoing automation initiatives that are expected to further enhance profitability. These results reinforce the market’s view that IDEX can sustain earnings momentum.
How does IDEX (IEX)'s valuation compare to its peers?
IDEX trades at a forward P/E of 33.35, slightly above the peer average of 29.2. Its market cap of $17.3 billion places it among the larger players in the specialty industrial machinery space. The 52‑week high of $243.80 and low of $157.25 suggest a 17.7% range, indicating moderate volatility relative to peers. While the valuation premium reflects expectations of margin expansion, it also implies limited downside cushion if earnings falter. Investors comparing IDEX to peers such as AMETEK should consider the company’s higher gross margin and share‑buyback activity as mitigating factors.
Does IDEX (IEX) pay a dividend?
IDEX does not currently distribute a dividend to shareholders. Instead, the company focuses on reinvesting earnings into research and development, automation projects, and share‑repurchase initiatives. This capital allocation strategy aligns with its growth objectives and aims to enhance long‑term shareholder value. Investors seeking income may need to look at alternative sources within the industrials sector. The absence of a dividend does not preclude the potential for capital appreciation through share price gains.
What are the primary price drivers for IDEX (IEX) in the next 12 months?
Looking ahead, the main price drivers will likely include the continued expansion of automation solutions across all three segments, which can lift operating leverage. Strong demand in water treatment and energy markets is expected to support fluid‑handling sales, while the health & science segment benefits from rising life‑science spending. Share‑buyback activity, which has already reduced the share count by 25%, may further boost earnings per share. Positive earnings guidance from the company’s Q3 2026 forecast could reinforce investor confidence. Finally, favorable macro‑economic data that lifts industrial spending would provide a tailwind.
How does IDEX (IEX)'s share buyback program influence its earnings?
The buyback program has already repurchased about 25.04% of the company’s shares for roughly $1.74 billion since 2008, effectively tightening the share base. This reduction in diluted shares elevates EPS, making the company’s earnings appear stronger on a per‑share basis. By returning capital directly to shareholders, IDEX signals confidence in its cash‑flow generation. The program also exerts upward pressure on the stock price, as demand for shares rises. However, the program’s long‑term impact depends on the company’s ability to sustain cash flow and margin expansion.
What is the outlook for IDEX (IEX) automation demand?
Automation demand is projected to grow as industrial customers seek efficiency gains and cost reductions. IDEX’s investment in digital twins and predictive maintenance tools positions it well to capture this trend. In Q2 2026, automation‑related revenue contributed to a 6% YoY increase in the Fluid & Metering Technologies segment. Analysts forecast that automation could account for up to 15% of total revenue by 2028, provided supply chains remain stable. Continued focus on automation is expected to reinforce IDEX’s margin profile.
Learn More
What Is RSI and How to Read It Learn how the Relative Strength Index helps you measure momentum and identify overbought or oversold conditions.
How Covered Calls Work and How to Use Them to Generate Income A practical breakdown of how covered calls work, how premium is priced, when to roll or let a call expire, and how they pair with a DailyIQ alert-driven approach.
What Are Bollinger Bands and How to Read Them Learn how Bollinger Bands measure volatility, identify breakouts, and highlight overextended price conditions.
What Are Order Blocks? Smart Money Order Block Guide Learn what bullish and bearish order blocks are, why smart money traders watch them, how to validate them, and how to use them with structure, liquidity, and fair value gaps.
Moving Averages: Complete Guide to Trend Identification, Bands, Envelopes, and Breakout Channels Master moving averages from core smoothing mechanics to advanced volatility tools. Learn SMA vs EMA, crossover signals, whipsaws, envelopes, Bollinger/Keltner/STARC bands, Donchian breakouts, and how institutions confirm trends and filter false signals.
Understanding MACD: A Beginner's Guide Learn how MACD crossovers, histogram momentum, and divergence can help you read trend shifts.
Recent News Coverage
Most recent articles, ranked by recency (click to expand).